Capula Management »

Apellis Pharmaceuticals shares owned by Capula Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Capula Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3M 56k 40.23

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr China Lg-cap Etf Put Option (FXI)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Clearwater Analytics Hldgs I Cl A (CWAN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)

View all positions for Capula Management

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals